Phase 2 study shows safety and immunogenicity of SARS-CoV-2 recombinant protein vaccine

While the currently available coronavirus disease 2019 (COVID-19) vaccines have shown great efficacy in reducing the risk of hospitalization upon infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the availability of these vaccines is still lacking on a global scale. Further, in certain subpopulations, adolescent boys have demonstrated a higher than the average number of adverse events upon receiving […]

» Read more

New research contributes to understanding of cystic fibrosis

Researchers at the University of Saskatchewan (USask) are hopeful new understanding of cellular defects related to cystic fibrosis (CF) could help pave the way for treatment of the disease. A team in the College of Medicine led by Drs. Juan Ianowski (Ph.D.) and Julian Tam (MD) found that sodium transport is abnormal in lungs with CF. The researchers, affiliated with […]

» Read more

HPV vaccine hesitancy has now stabilized or increased in some ethnic and age groups

A study that tracked parental opinion about the human papillomavirus (HPV) vaccine showed that after hesitancy decreased for several years, hesitancy has now either stabilized or increased in some ethnic and age groups, according to results presented at the virtual 14th AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved, held October 6-8, […]

» Read more

Factbox – Latest on the worldwide spread of the coronavirus

(Reuters) – China reported no new local COVID-19 cases for the first time in more than three weeks, while Japan is gauging the right time to restart a popular subsidised travel programme that was suspended last year.FILE PHOTO: People walk with their luggage outside the Beijing Railway Station ahead of China’s National Day and the upcoming Golden Week holiday, following […]

» Read more
1 687 688 689 690 691 1,330